Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
3
result was found. Results that relate to
Progression-free survival
Real-world study of sintilimab combined with bevacizumab in patients with advanced hepatocellular carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):485-490.
971 times
663 times
SU Zhan
CHE Jinhui
PEI Ruifeng
Advanced hepatocellular carcinoma
Sintilimab
Bevacizumab
Clinical efficacy
Safety
Overall survival
Progression-free survival
Details
Efficacy and safety of tislelizumab combined with sorafenib in the treatment for unresectable hepatocellular carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,27(8):1136-1342.
913 times
194 times
JIANG Jinghua
HU Yiting
Tirilizumab
Sorafenib
Unresectable
Hepatocellular carcinoma
Objective response rate
Disease control rate
Progression-free survival
Overall survival
Details
Effects of statins on survival outcomes in patients with metastatic renal cell carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,28(1):28-33.
719 times
161 times
GAO Shiliang
HE Xiaoqi
ZHENG Huijie
YANG Di
YU Mingzhu
Metastatic renal cell carcinoma
Statins
Survival outcomes
Overall survival
Progression-free survival
Objective response rate
Disease control rate
Details
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University